Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)

R. Kanesvaran; B. Biswas; P. Danchaivijitr; C. S. Lim; B. Karabulut; Y. F. Wong; H. S. Coskun; C-H. Chang; I. Cicin; S. Ingles; K. Slimane; M. Erman

Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)

R. Kanesvaran
, B. Biswas
, P. Danchaivijitr
, C. S. Lim
, B. Karabulut
, Y. F. Wong
, H. S. Coskun
, C-H. Chang
, I. Cicin
, S. Ingles
, K. Slimane
, M. Erman

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	30
Publication status	Published - Nov 2019
Event	European-Society-for-Medical-Oncology (ESMO) Asia Congress - Singapore, Singapore Duration: 22 Nov 2019 → 24 Nov 2019

Cite this

Kanesvaran, R., Biswas, B., Danchaivijitr, P., Lim, C. S., Karabulut, B., Wong, Y. F., Coskun, H. S., Chang, C.-H., Cicin, I., Ingles, S., Slimane, K., & Erman, M. (2019). Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE). Annals of Oncology, 30.

@article{79ee1fe3a22b4e72bb4b268e48796d47,

title = "Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)",

author = "R. Kanesvaran and B. Biswas and P. Danchaivijitr and Lim, \{C. S.\} and B. Karabulut and Wong, \{Y. F.\} and Coskun, \{H. S.\} and C-H. Chang and I. Cicin and S. Ingles and K. Slimane and M. Erman",

year = "2019",

month = nov,

language = "English",

volume = "30",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

note = "European-Society-for-Medical-Oncology (ESMO) Asia Congress ; Conference date: 22-11-2019 Through 24-11-2019",

}

Kanesvaran, R, Biswas, B, Danchaivijitr, P, Lim, CS, Karabulut, B, Wong, YF, Coskun, HS, Chang, C-H, Cicin, I, Ingles, S, Slimane, K & Erman, M 2019, 'Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)', Annals of Oncology, vol. 30.

Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE). / Kanesvaran, R.; Biswas, B.; Danchaivijitr, P. et al.
In: Annals of Oncology, Vol. 30, 11.2019.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries

T2 - European-Society-for-Medical-Oncology (ESMO) Asia Congress

AU - Kanesvaran, R.

AU - Biswas, B.

AU - Danchaivijitr, P.

AU - Lim, C. S.

AU - Karabulut, B.

AU - Wong, Y. F.

AU - Coskun, H. S.

AU - Chang, C-H.

AU - Cicin, I.

AU - Ingles, S.

AU - Slimane, K.

AU - Erman, M.

PY - 2019/11

Y1 - 2019/11

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000503487700531&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0923-7534

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

Y2 - 22 November 2019 through 24 November 2019

ER -

Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)

Other files and links

Cite this